🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease

Recruitingn/aAges any - anyAllSichuan Provincial People's Hospital
NCT06819410 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Efficacy and safety of amphotericin B and azoles in the treatment of invasive fungal disease

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * There is no age limit, gender is not limited * Patients with invasive fungal disease who are treated with polyene antifungals or azole antifungals should be treated for ≥ 7 days. Exclusion Criteria: * Patients with incomplete data or other factors affecting the clinical outcome judgement * Patients who are judged by the investigator to be unsuitable to participate in this study.
💊

What it tests

  • Not listed
📍

Where

1 site
Sichuan Provincial People's Hospital
Chengdu, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy